Science 37 Holdings, Inc.

Science 37 Holdings, Inc., trading under the ticker LSAQ, is a healthcare technology company that completed its business combination with LifeSci Acquisition 2 Corp, sponsored by LifeSci Capital, following the SPAC's 2021 IPO. The company operates in the decentralized clinical trials sector, providing a technology-enabled platform that allows biopharmaceutical sponsors to conduct clinical research using patients in their own homes rather than traditional research sites. The May 2022 8-K filing reflects Science 37's status as a post-merger public company continuing its reporting obligations under the Securities Exchange Act. Sign up for full data, filings history, and deal analytics on SpacDesk.